Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers

International Journal of Pharmaceutics

Volumn 366, Issue 1-2, 2009, Pages 149-153

  Armando, Yara Popst ^a   Schramm, Simone Grigoleto ^a   de Freitas Silva, Marina ^a   Kano, Eunice Kazue ^a   Koono, Eunice Emiko Mori ^a   Porta, Valentina ^a   dos Reis Serra, Cristina Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bioequivalence; LC MS; Ondansetron; Plasma

Indexed keywords

ONDANSETRON; PROPRANOLOL; UNCLASSIFIED DRUG; VONAU FLASH;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG HALF LIFE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TABLET FORMULATION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

ADMINISTRATION, ORAL; ADULT; ANTIEMETICS; AREA UNDER CURVE; BRAZIL; CHROMATOGRAPHY, LIQUID; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; ONDANSETRON; TABLETS; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY;

EID: 57949102372     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.09.021     Document Type: Article

References (18)

1. Annemas L., Strens D., Lox E., Petit C., and Malonne H. Cost-effectiveness analysis of aprepitant in the prevention of chemotherapy-induced nausea and vomiting in Belgium. Support. Care Cancer 16 (2008) 905-915
2. Bauer S., Stormer E., Kaiser R., Tremblay P.B., Brockmoller J., and Roots I. Simultaneous determination of ondansetron and tropisetron in human plasma using HPLC with UV detection. Biomed. Chromatogr. 16 (2002) 187-190
3. Biradar S.S., Bhagavati S.T., and Kupassad I.J. Fast dissolving drug delivery systems: a brief overview. Internet J. Pharmacol. 4 (2006)
4. Bozigian H.P., Pritchard J.F., Gooding A.E., and Pakes G.E. Ondansetron absorption in adults: effect of dosage form, food, and antiacids. J. Pharm. Sci. 83 (1994) 1011-1013
5. Chandrasekar D., Ramakrishna S., and Diwan P.V. A rapid, sensitive and validated method for the determination of ondansetron in human plasma by reversed-phase high-pressure liquid chromatography. Arzneimittelforschung 54 (2004) 655-659
6. Currow D.C., Coughlan M., Fardell B., Cooney N.J., and Pain J. Use of ondansetron in palliative medicine. J. Pain Symptom Manage. 13 (1997) 302-307
7. Dépôt M., Leroux S., and Caillé G. High-resolution liquid chromatographic method using ultraviolet detection for determination of ondansetron in human plasma. J. Chromatogr. B 693 (1997) 399-406
8. Dotsikas Y., Kousoulos C., Tsatsou G., and Loukas Y.L. Development and validation of rapid 96-well format based liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analysis method for ondansetron in human plasma. J. Chromatogr. B 836 (2006) 79-82
9. GlaxoSmithKline. Zofran, Product Monograph (2006), GlaxoSmithKline, Mississauga, Ontario pp. 1-31
10. Habib W., Pritchard J.F., Bozigian H.P., Gooding A.E., Griffin R.H., Mitchell R., Bjurstrom T., Panella T.L., Huang A.T., and Hansen L.A. Fast-dissolve drug delivery system. Crit. Rev. Ther. Drug Carrier Syst. 17 (2000) 61-72
11. Hsyu P.H., Pritchard J.F., Bozigian H.P., Lloyd T.L., Griffin R.H., Shamburek R., Krishna G., and Barr W.H. Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum. Pharm. Res. 11 (1994) 156-159
12. Jackson A.J. Generics and Bioequivalence (1994), CRC Press pp. 1-203
13. Lam Y.W.F., Javors M.A., Ait-Daoud N., Roache J.D., and Johnson B.A. Relative bioavailability of an extemporaneous ondansetron 4 mg capsule formulation versus solution. Pharmacotherapy 24 (2004) 477-481
14. Liu J., and Stewart J.T. High-performance liquid chromatographic analysis of ondansetron enantiomers in human serum using a reversed-phase cellulose-based chiral stationary phase and solid-phase extraction. J. Chromatogr. B 694 (1997) 179-184
15. Porta V., Schramm S.G., Kano E.K., Koono E.E., Armando Y.P., Fukuda K., and Serra C.H.R. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies. J. Pharm. Biomed. Anal. 46 (2008) 143-147
16. Ritschel W.A. Handbook of Basic Pharmacokinetics (1992), Drug Intelligence, Hamilton pp. 1-588
17. Simpson K.H., and Hicks F.M. Clinical pharmacokinetics of ondansetron. A review. J. Pharm. Pharmacol. 48 (1996) 774-781
18. Xu X., Barlett M.G., and Stewart J.T. Determination of ondansetron and its hidroxy metabolites in human serum using solid-phase extraction and liquid chromatography/positive ion electrospray tandem mass spectrometry. J. Mass Spectrom. 35 (2000) 1329-1334